Development and maintenance of FDA-argos 2 containing regulatory grade reference genomes for diagnostic use and regulatory science
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00167
- Awardee
-
Embleema Inc. UEI PQGTDJ2DF644
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $9,751,139
Award facts
- Opportunity
-
- FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2100123 · Posted Nov 20, 2020
- Contract value 100% obligated
- $9,751,139.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $835,000 | |
| Other Administrative Action | $600,000 | |
| Other Administrative Action | $1,396,916 | |
| Other Administrative Action | $1,500,000 | |
| Exercise an Option | $3,427,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,992,223 |
About this award
This federal contract award was made by the Food and Drug Administration (FDA) to Embleema Inc. for the development and maintenance of the FDA-ARGOS 2 system, which contains regulatory-grade reference genomes for diagnostic use and regulatory science. The contract has a ceiling value of $9,751,139.00 and a period of performance through September 16, 2025. The contract was awarded on September 13, 2021 under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which seeks research and development proposals across multiple areas of regulatory science to support the FDA's mission. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75F40121C00167?
75F40121C00167 was awarded to Embleema Inc. by Food and Drug Administration (Department of Health and Human Services) on September 13, 2021.
How much is contract 75F40121C00167 worth?
The government has obligated $9,751,139 on 75F40121C00167.
Was contract 75F40121C00167 competed?
The extent of competition for 75F40121C00167 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award